Image Systems halts acquisition of Nortech
Image Systems halts acquisition of NortechMonitor vendor Image Systems has withdrawn its letter of intent to purchase the Imaging Systems division of Nortech Systems. The Minnetonka, MN-based firm said the two companies could not come to an
Image Systems halts acquisition of Nortech
Monitor vendor Image Systems has withdrawn its letter of intent to purchase the Imaging Systems division of Nortech Systems. The Minnetonka, MN-based firm said the two companies could not come to an agreement during the due diligence process on how to address the existing Nortech warranty liability on previously shipped products.
Image Systems has been designing and manufacturing high-resolution displays since 1988; currently about 80% of the companys business is in medical imaging. Its OEM customers include GE, Toshiba, and Marconi; other customers include DR Systems, Kodak/Cemax-Icon, and IBM (for DIN-PACS).
Image Systems and Nortech, located in Plymouth, MN, have a long history together. Both originally began as divisions of Cassette Powered Typewriters, which is no longer in business. They became competitors in the last few years when Nortech first entered the medical market.
© 2000 Miller Freeman, Inc., a United News & Media company
- Search again
- Homepage
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
